The synthesis and further hydrogenation of fluorinated polynorbornene dicarboximides is reported, using p‐toluenesulfonyl hydrazide and Wilkinson's catalysts, respectively. Despite improving the resistance to thermo‐oxidative degradation, it is observed that the hydrogenation of the backbone double bonds in the polymer also decreases the thermomechanical properties. Afterward, a comparative study of gas transport in membranes based on these hydrogenated polynorbornenes, as well as in their unsaturated analogues, is carried out. The gases studied are hydrogen, oxygen, nitrogen, carbon dioxide, methane, ethane, ethylene, and propylene. After hydrogenation, the gas permselectivity of the membranes is enhanced as a consequence of the decrease of both the gas solubility and the gas diffusion.
Osthole (Ost), one of the major components of Cnidium monnieri (L.) Cusson, is had the structure of an isopentenoxy-coumarin with a range of pharmacological activities. In the present study, the metabolism of Ost in male Sprague-Dawley rats was investigated by identifying Ost metabolites excreted in rat urine.
Following an oral dose of 40 mg/kg Ost, 10 phase I and 3 phase II metabolites were isolated from the urine of rats, and their structures identified on the basis of a range of spectroscopic data, including 2D-NMR techniques. These metabolites were fully characterized as 5′-hydroxyl-osthole (M-1), osthenol (M-2), 4′-hydroxyl-osthole (M-3), 3, 5′-dihydroxyl-osthole (M-4), 5′-hydroxyl-osthenol (M-5), 4′-hydroxyl-2′, 3′-dihydro-osthenol (M-6), 4′-hydroxyl-osthenol (M-7), 3, 4′-dihydroxyl-osthole (M-8), 2′, 3′-dihydroxyl-osthole (M-9), 5′-hydroxyl-2′, 3′-dihydroosthole (M-10), osthenol-7-O-β-D-glucuronide (M-11), osthole-4′-O-β-D-glucuronide (M-12) and osthole-5′-O-β-D-glycuronate (M-13). This is the first identification of M-1, M-3 to M-13in vivo.
On the basis of the metabolites profile, a possible metabolic pathway for Ost metabolism in rats has been proposed. This is the first systematic study on the phases I and II metabolites of 8-isopentenoxy-coumarin derivative.